Search Results - "Yoca, G."

P.3.d.044 A randomised, double-blind, placebo controlled, cross-over trial of adjunctive L-arginine in schizophrenia by Kocyigit, Y, Ayhan, Y, Yoca, G, Karahan, S, Yazici, M.K

Get full text

Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia by Lin, Bochao D, Pinzón-Espinosa, Justo, Blouzard, Elodie, van der Horst, Marte Z, Okhuijsen-Pfeifer, Cynthia, van Eijk, Kristel R, Guloksuz, Sinan, Peyrot, Wouter J, Luykx, Jurjen J

“…Predictors consistently associated with psychosis liability and course of illness in schizophrenia (SCZ) spectrum disorders (SSD), including the need for…”
Get more information

SUN-P252: Evaluating the Effects of Body Composition on Metabolic Profile in Patients with Schizophrenia by Türkoğlu, I., Akal Yıldız, E., Mercanlıgil, S.M., Yoca, G., Yazıcı, K.

Get full text

SUN-P302: Evaluating the Effects of Dietary Fatty Acid and Antioxidant Vitamin Intake on Metabolic Profile in Patients with Schizophrenia by Türkoğlu, I., Akal Yıldız, E., Mercanlıgil, S.M., Yoca, G., Yazıcı, K.

Get full text

PT07.5: Evaluating the Effects of Physical Activity Status on Metabolic Profile in Patients with Schizophrenia by Türkoğlu, I., Akal Yıldız, E., Mercanlıgil, S.M., Yoca, G., Yazıcı, K.

Get full text

Genome-wide association analyses of symptom severity among clozapine-treated patients with schizophrenia spectrum disorders by Okhuijsen-Pfeifer, C., van der Horst, M. Z., Bousman, C. A., Lin, B., van Eijk, K. R., Ripke, S., Ayhan, Y., Babaoglu, M. O., Bak, M., Alink, W., van Beek, H., Beld, E., Bouhuis, A., Edlinger, M., Erdogan, I. M., Ertuğrul, A., Yoca, G., Everall, I. P., Görlitz, T., Grootens, K. P., Gutwinski, S., Hallikainen, T., Jeger-Land, E., de Koning, M., Lähteenvuo, M., Legge, S. E., Leucht, S., Morgenroth, C., Müderrisoğlu, A., Narang, A., Pantelis, C., Pardiñas, A. F., Oviedo-Salcedo, T., Schneider-Thoma, J., Schreiter, S., Repo-Tiihonen, E., Tuppurainen, H., Veereschild, M., Veerman, S., de Vos, M., Wagner, E., Cohen, D., Bogers, J. P. A. M., Walters, J. T. R., Yağcıoğlu, A. E. Anil, Tiihonen, J., Hasan, A., Luykx, J. J.

“…Clozapine is the most effective antipsychotic for patients with treatment-resistant schizophrenia. However, response is highly variable and possible genetic…”
Get full text